Zacks.com on MSN2d
BD Stock Rises on Biosero Deal for AI-Powered Robotic Cytometry Tech
BD and Biosero collaborate to integrate robotic automation with flow cytometry technology, aiming to accelerate drug discovery.
BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of ...
BD And Biosero Partner To Integrate Robotics With Flow Cytometry
BD. (BDX), a global medical technology company, and Biosero, a developer of laboratory automation solutions, Thursday announced that ...
Pharmabiz2d
BD & Biosero collaborate to enable robotic integration with flow cytometers used in drug discovery and development
Franklin Lakes, New Jersey Saturday, January 25, 2025, 10:00 Hrs [IST] ...
Contract Pharma3d
BD, Biosero Partner to Enable Robotic Integration with Flow Cytometers
BD, a global medical technology company, and Biosero, a developer of laboratory automation solutions, have joined forces to ...
Cure Today4d
Understanding the Concept of MRD for Patients With Cancer
Dr. Christopher Flowers discusses MRD testing in cancer care, why this is an important concept to understand and how it ...
Cure Today10d
An Expert Breaks Down the Meaning of MRD Testing in Cancer Care
Dr. Christopher R. Flowers delved into the meaning of MRD, discussing different ways that it may be tested for in patients ...
Becton Dickinson, Biosero announce framework collaboration agreement
Becton, Dickinson and Company and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, announced a ...
Sysmex America Expands Operations with Plans for New Reagent Manufacturing, Distribution and Service Center in Brazil
Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and ...
eLife7d
Wnt specifically induces FZD5/8 endocytosis and degradation and the involvement of RSPO-ZNRF3/RNF43 and DVL
Frizzled (FZD) proteins are the principal receptors of the Wnt signaling pathway. However, whether Wnt ligands induce FZD endocytosis and degradation remains elusive. The transmembrane E3 ubiquitin ...
Joplin Globe4d
bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic
bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic ...
News Medical on MSN2d
Revvity ignites scientific breakthroughs at SLAS2025
Revvity, Inc. is set to unveil its groundbreaking new Phenologic.AI™ software at SLAS2025 in San Diego, January 27-29.